Silo Pharma (SILO) Times Interest Earned (2018 - 2026)
Silo Pharma (SILO) posted Times Interest Earned of -$10.24 for Q1 2026, up 73.43% sequentially from -$38.56 in Q4 2025, and down 65.02% YoY from -$29.28 in Q1 2025.
Silo Pharma (SILO) Times Interest Earned (2018 - 2026) Analysis & Trends
Silo Pharma has reported Times Interest Earned for 9 years, with the latest figure at -$10.24 in Q1 2026.
- Quarterly Times Interest Earned fell 65.02% year-over-year to -$10.24 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.71 (down 10.02% YoY) and the FY2025 annual result came in at -$0.88, up 30.27% from the prior year.
- Times Interest Earned advanced to -$10.24 in Q1 2026 per SILO's latest filing, from -$38.56 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.53 in Q2 2024 and troughed at -$13808.0 in Q4 2022.
- A 5-year average of -$1601.5 and a median of -$11.03 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned sank 71479833.34% in 2022, then surged 99.42% in 2025.
- Over 5 years, Times Interest Earned stood at -$13808.0 in 2022, then soared by 69.13% to -$4262.7 in 2023, then slumped by 55.25% to -$6618.1 in 2024, then soared by 99.42% to -$38.56 in 2025, then jumped by 73.43% to -$10.24 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$10.24, -$38.56, and -$11.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | -324.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.32 |
| Mar 31, 2026 | -10.24 |
| Dec 31, 2025 | -38.56 |
| Sep 30, 2025 | -11.03 |
| Jun 30, 2025 | -7.59 |
| Mar 31, 2025 | -6.21 |
| Dec 31, 2024 | -6,618.07 |
| Sep 30, 2024 | -5.54 |
| Jun 30, 2024 | -0.53 |
| Mar 31, 2024 | -1.06 |
| Dec 31, 2023 | -4,262.73 |
| Sep 30, 2023 | -77.42 |
| Jun 30, 2023 | -90.87 |
| Mar 31, 2023 | -4.79 |
| Dec 31, 2022 | -13,807.98 |
| Sep 30, 2022 | -528.48 |
| Jun 30, 2022 | -1,746.59 |
| Mar 31, 2022 | -7.41 |
| Dec 31, 2021 | -5,746.44 |
| Sep 30, 2021 | -7.93 |